Why Altimmune Shares Are Flying High Today
Shares of Altimmune (NASDAQ: ALT) were flying 16.7% higher as of 11:27 a.m. EDT on Monday. The big jump came after the company and the University of Alabama at Birmingham (UAB) reported positive preclinical results for intranasal COVID-19 vaccine candidate AdCOVID.
Altimmune and UAB reported that mice receiving AdCOVID demonstrated a "strong systemic antibody response" 14 days after receiving a single intranasal dose of the vaccine candidate. Lead investigator and UAB professor Dr. Frances Lund said, "Stimulation of immunity at this level just 14 days after a single dose is impressive for any vaccine, and is particularly notable for a potential coronavirus vaccine."
Image source: Getty Images.
Source Fool.com
